Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Strategy
MSTR
US Stock MarketDetailed Quotes
INCY Incyte
- 71.130
- +0.340+0.48%
Close Mar 10 16:00 ET
- 70.610
- -0.520-0.73%
Pre 08:50 ET
13.77BMarket Cap474.20P/E (TTM)
71.890High69.755Low1.24MVolume69.940Open70.790Pre Close88.06MTurnover0.77%Turnover Ratio474.20P/E (Static)193.52MShares83.95052wk High3.99P/B11.47BFloat Cap50.35052wk Low--Dividend TTM161.30MShs Float153.150Historical High--Div YieldTTM3.02%Amplitude1.850Historical Low71.047Avg Price1Lot Size
About Incyte Company
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.
Company Profile
SymbolINCY
Company NameIncyte
Listing DateNov 4, 1993
Issue Price7.50
Founded1991
CEOMr. Herve Hoppenot
MarketNASDAQ
Employees2617
Fiscal Year Ends12-31
Address1801 Augustine Cut-Off
CityWilmington
ProvinceDelaware
CountryUnited States of America
Zip Code19803
Phone1-302-498-6700
Websitehttp://www.incyte.com
Company Executives
- Name
- Position
- Salary
- Herve Hoppenot
- Chairman of the Board, President and Chief Executive Officer
- 16.66M
- Dr. Steven H. Stein, M.D.
- Executive Vice President and Chief Medical Officer
- 5.63M
- Christiana Stamoulis, M.B.A.
- Executive Vice President and Chief Financial Officer
- 5.08M
- Thomas Tray
- Vice President and Chief Accounting Officer
- --
- Barry P. Flannelly, Pharm.D.
- Executive Vice President and General Manager, North America
- 4.09M
- Matteo Trotta
- Executive Vice President and General Manager, Dermatology US
- --
- Lee Heeson
- Executive Vice President, Incyte International
- --
- Sheila A Denton
- Executive Vice President, General Counsel and Corporate Secretary
- --
- Paula J. Swain
- Executive Vice President, Human Resources
- --
- Mohamed Khairie Issa
- Executive Vice President and Head of US Oncology
- --
- Michael James Morrissey
- Executive Vice President and Head of Global Technical Operations
- --
- Vijay K. Iyengar
- Executive Vice President, Global Strategy and Corporate Development
- --
- Dr. Pablo J. Cagnoni, M.D.
- President and Head of Research and Development
- 15.83M
- Dr. Otis W. Brawley,M.D.
- Independent Director
- 454.76K
- Jean-Jacques Bienaime
- Independent Director
- 478.76K
- Dr. Edmund P. Harrigan, M.D.
- Independent Director
- 482.26K
- Paul J. Clancy
- Independent Director
- 479.76K
- Dr. Jacqualyn A. Fouse, PhD
- Independent Director
- 466.26K
- Julian C. Baker
- Lead Independent Director
- 512.76K
- Dr. Susanne Schaffert, PhD
- Independent Director
- 444.76K
- Dr. Katherine A. High, M.D.
- Independent Director
- 454.76K